Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response

Molecular Pharmaceutics

Volumn 5, Issue 1, 2008, Pages 35-41

  Moreau, Amélie ^b   Vilarem, Marie José ^b   Maurel, Patrick ^b   Pascussi, Jean Marc ^a  

^a INSERM   (France)

^b NONE

Author keywords

CAR; Glucose metabolism; Inflammation; Lipid metabolism; PXR

Indexed keywords

CONSTITUTIVE ANDROSTANE RECEPTOR; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HEPATOCYTE NUCLEAR FACTOR 3BETA; PREGNANE X RECEPTOR; TRANSCRIPTION FACTOR;

ENDOCRINE DISEASE; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GLUCOSE HOMEOSTASIS; HUMAN; INFLAMMATION; LIPID METABOLISM; LIPOGENESIS; LIVER; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

ANIMALS; GLUCOSE; HUMANS; INFLAMMATION; LIPID METABOLISM; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRANSCRIPTION FACTORS;

EID: 39749171761     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp700103m     Document Type: Review

References (57)

1. Morere, P. Information obtained by liver biopsy in 100 tuberculous patients. Sem. Hop. 1975, 51 (31-34), 2095-102.
2. Piriou, A. Fatty liver induced by high doses of rifampicin in the rat: possible relation with an inhibition of RNA polymerases in eukariotic cells. Arch. Toxicol. Suppl. 1979, (2), 333-7.
3. Truhaut, R. Liver steatogenic power of high doses of rifampicin in rats. C. R. Acad. Sci. Hebd. Seances Acad. Sci. D 1978, 286 (6), 493-7.
4. Oscarson, M. Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. Clin. Pharmacol. Ther. 2006, 80 (5), 440-456.
5. Grieco, A. Fatty liver and drugs. Eur. Rev. Med. Pharmacol. Sci. 2005, 9 (5), 261-3.
6. Calandre, E. P. Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital. Acta Neurol. Scand. 1991, 83 (4), 250-3.
7. Luoma, P. V. Microsomal enzyme induction, lipoproteins and atherosclerosis. Pharmacol. Toxicol. 1988, 62 (5), 243-9.
8. Kassam, A. The peroxisome proliferator response element of the gene encoding the peroxisomal beta-oxidation enzyme enoyl-CoA hydratase/3- hydroxyacyl-CoA dehydrogenase is a target for constitutive androstane receptor beta/9-cis-retinoic acid receptor-mediated transactivation. J. Biol. Chem. 2000, 275 (6), 4345-50.
9. Ueda, A. Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol. Pharmacol 2002, 61 (1), 1-6.
10. Nakamura, K. Nuclear pregnane X receptor cross-talk with FoxA-2 to mediate drug-induced regulation of lipid metabolism in fasting mouse liver. J. Biol. Chem. 2007, 282 (13), 9768-76.
11. Wolfrum, C. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 2004, 432 (7020), 1027-32.
12. Wolfram, C. Insulin regulates the activity of forkhead transcription factor Hnf-3beta/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization. Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (20), 11624-9.
13. Louet, J. F. The coactivator PGC-1 is involved in the regulation of the liver carnitine palmitoyltransferase I gene expression by cAMP in combination with HNF4 alpha and cAMP-response element-binding protein (CREB). J. Biol. Chem. 2002, 277 (41), 37991-8000.
14. Zhang, Y. Peroxisomal proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha) enhances the thyroid hormone induction of carnitine palmitoyltransferase I (CPT-I alpha). J. Biol. Chem. 2004, 279 (52), 53963-71.
15. Napal, L.; Marrero, P. F.; Haro, D. An intronic peroxisome proliferator-activated receptor-binding sequence mediates fatty acid induction of the human carnitine palmitoyltransferase 1A. J. Mol. Biol. 2005, 354 (4), 751-9.
16. Li, T.; Chiang, J. Y. Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288 (1), G74-84.
17. Shiraki, T. Activation of orphan nuclear constitutive androstane receptor requires subnuclear targeting by peroxisome proliferator-activated receptor gamma coactivator-1 alpha. A possible link between xenobiotic response and nutritional state. J. Biol. Chem. 2003, 278 (13), 11344-50.
18. Bhalla, S. Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha. Functional implications in hepatic cholesterol and glucose metabolism. J. Biol. Chem. 2004, 279 (43), 45139-47.
19. Miao, J. Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1alpha. J. Biol. Chem. 2006, 281 (21), 14537-46.
20. Zhou, J. A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway. J. Biol. Chem. 2006, 281 (21), 15013-20.
21. Coburn, C. T. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J. Biol. Chem. 2000, 275 (42), 32523-9.
22. Feng, J. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J. Lipid Res. 2000, 41 (5), 688-96.
23. Schadinger, S. E. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am. J. Physiol. Endocrinol. Metab. 2005, 288 (6), E1195-205.
24. Zhang, Y. L. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. J. Biol. Chem. 2006, 281 (49), 37603-15.
25. LaFave, L. T.; Augustin, L. B.; Mariash, C. N. S14: insights from knockout mice. Endocrinology 2006, 147 (9), 4044-7.
26. Campbell, M. C.; Anderson, G. W.; Mariash, C. N. Human spot 14 glucose and thyroid hormone response: characterization and thyroid hormone response element identification. Endocrinology 2003, 144 (12), 5242-8.
27. Feng, X. Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol. Endocrinol. 2000, 14 (7), 947-55.
28. Oppenheimer, J. H. Regulation of gene S-14 by triiodothyronine in liver. Horm. Metab. Res. Suppl. 1987, 17, 1-5.
29. Kinlaw, W. B. Direct evidence for a role of the "spot 14" protein in the regulation of lipid synthesis. J. Biol. Chem. 1995, 270 (28), 16615-8.
30. Sanchez-Rodriguez, J. The spot 14 protein inhibits growth and induces differentiation and cell death of human MCF-7 breast cancer cells. Biochem. J. 2005, 390 (Pt 1), 57-65.
31. Zhu, Q. The Spot 14 protein is required for de novo lipid synthesis in the lactating mammary gland. Endocrinology 2005, 146 (8), 3343-50.
32. Tien, E. S.; Negishi, M. Nuclear receptors CAR and PXR in the regulation of hepatic metabolism. Xenobiotica 2006, 36 (10-11), 1152-63.
33. Argaud, D. Inhibition of gluconeogenesis in isolated rat hepatocytes after chronic treatment with phenobarbital. Biochem. J. 1991, 280 (Pt 3), 663-9.
34. Kodama, S. Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes. Mol. Cell. Biol. 2004, 24 (18), 7931-40.
35. Lahtela, J. T.; Arranto, A. J.; Sotaniemi, E. A. Enzyme inducers improve insulin sensitivity in non-insulin-dependent diabetic subjects. Diabetes 1985, 34 (9), 911-6.
36. Fox, G. R.; Virgo, B. B. The effects of phenobarbital, atropine, L-alpha-methyldopa, and DL-propranolol on dieldrin-induced hyperglycemia in the adult rat. Toxicol. Appl. Pharmacol. 1985, 78 (3), 342-50.
37. Fan, W. Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of FoxO1 with androgen receptor. J. Biol. Chem. 2007, 282 (10), 7329-38.
38. Zhao, H. H. Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions. J. Biol. Chem. 2001, 276 (30), 27907-12.
39. Herzig, S. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001, 413 (6852), 179-83.
40. Yoon, J. C. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001, 413 (6852), 131-8.
41. Kodama, S., et al., Human nuclear pregnane X receptor cross-talk with CREB to repress cAMP activation of the glucose-6-phosphatase gene. Biochem. J., 2007.
42. Rosenberg, D. Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues. Ann. NY. Acad. Sci. 2002, 968, 65-74.
43. Lin, B.; Morris, D. W.; Chou, J. Y. The role of HNF1alpha, HNF3gamma, and cyclic AMP in glucose-6-phosphatase gene activation. Biochemistry 1997, 36 (46), 14096-106.
44. Park, E. A. The role of the CCAAT/enhancer-binding protein in the transcriptional regulation of the gene for phosphoenolpyruvate carboxykinase (GTP). Mol. Cell. Biol. 1990, 10 (12), 6264-72.
45. Mendez-Pertuz, M.; Sanchez-Pacheco, A.; Aranda, A. The thyroid hormone receptor antagonizes CREB-mediated transcription. EMBO J. 2003, 22 (12), 3102-12.
46. Teng, S.; Piquette-Miller, M. The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice. J. Pharmacol. Exp. Ther. 2005, 312 (2), 841-8.
47. Paunescu, E. In vivo and in vitro suppression of humoral and cellular immunological response by rifampicin. Nature 1970, 228 (5277), 1188-90.
48. Doria, G.; Agarossi, G. Inhibition of the immune response in vitro by rifampicin and derivatives. Scand. J. Respir. Dis. Suppl. 1973, 84, 23-6.
49. Ibrahim, M. S. Antibiotics and immunity: effects of antibiotics on mitogen responsiveness of lymphocytes and interleukin-2 production. Chemioterapia 1988, 7 (6), 369-72.
50. Xie, W.; Tian, Y. Xenobiotic receptor meets NF-kappaB, a collision in the small bowel. Cell Metab. 2006, 4 (3), 177-8.
51. Zhou, C. Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. J. Clin. Invest. 2006, 116 (8), 2280-2289.
52. Vermeulen, L. Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. Biochem. Pharmacol. 2002, 64 (5-6), 963-70.
53. Langmann, T. Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology 2004, 127 (1), 26-40.
54. Dring, M. M. The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease. Gastroenterology 2006, 130 (2), 341-8, quiz 592.
55. Zelcer, N.; Tontonoz, P. SUMOylation and PPARgamma: wrestling with inflammatory signaling. Cell Metab. 2005, 2 (5), 273-5.
56. Pascussi, J. M., et al. The Tangle of Nuclear Receptors that Controls Xenobiotic Metabolism and Transport: Crosstalk and Consequences. Annu. Rev. Pharmacol. Toxicol. 2007.
57. Handschin, C.; Meyer, U. A. Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR. Arch. Biochem. Biophys. 2005, 433 (2), 387-96.